Pfizer rushes into bonds after signing jumbo loan
Pfizer has successfully syndicated its $22.5bn bridge facility, with 29 lenders committing to the deal in syndication. The result has prompted the US pharmaceuticals firm to enter the bond market to take out part of the loan and has also offered hope that banks will soon start underwriting jumbo transactions for European borrowers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
